<DOC>
	<DOC>NCT02730689</DOC>
	<brief_summary>The purpose of this study is to compare the pharmacokinetics of DP-R207 (Rosuvastatin 10mg and Ezetimibe 10mg fixed dose combinations) in comparison to each component administered alone in health male volunteers.</brief_summary>
	<brief_title>A Study to Compare the Pharmacokinetics of DP-R207 in Comparison to Each Component Administered Alone</brief_title>
	<detailed_description />
	<mesh_term>Ezetimibe</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Healthy male subjects age between 19 and 55 signed informed consent subjects have an allergy reaction of this drug</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>DP-R207</keyword>
	<keyword>Rosuvastatin</keyword>
	<keyword>Ezetimibe</keyword>
</DOC>